Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
Nova Ltd. (ticker NVMI) has filed a Form 144 with the U.S. Securities and Exchange Commission disclosing a planned sale of 2,051 ordinary shares. The shares will be sold through Oppenheimer & Co. Inc. on or about 25 June 2025 on the Nasdaq exchange. The filing assigns an aggregate market value of approximately US$509,714 to the proposed transaction, implying a reference price of roughly $248/share. Nova reports a total of 29,278,401 shares outstanding, so the planned sale represents only about 0.007 % of the float.
The seller previously disposed of 1,000 ordinary shares on 11 June 2025 for gross proceeds of US$235,000, indicating recent activity under Rule 144. Acquisition data show the shares originated from restricted stock unit (RSU) grants dated 31 Oct 2018 (730 sh), 6 Nov 2019 (664 sh) and 11 Nov 2020 (867 sh). No cash consideration or gifting was involved in the original awards.
The notice includes the standard representation that the seller is not in possession of undisclosed material adverse information. No Rule 10b5-1 plan date is provided, and no remarks were added by the filer.
For investors, the filing signals a modest insider monetisation event but, given its de-minimis size relative to the total share count, it is unlikely to have a material impact on Nova’s share-price dynamics.